On February 1, 2023, the FTC announced a proposed $1.5 million settlement with GoodRx Holdings, based on alleged violations of the Federal Trade Commission Act (“FTC Act”) and Health Breach Notification Rule (“HBNR”) for using advertising technologies on its websites and mobile app that resulted in the unauthorized disclosure of consumers’ personal and health information to advertisers and other third parties. On the same day, the U.S. Department of Justice, acting on behalf of the FTC, filed a Complaint and Proposed Stipulated Order detailing the FTC’s allegations and the terms of the proposed settlement.
Blog Editors
Recent Updates
- Video: How Modern Workplaces Navigate Generational Shifts: One-on-One with Jeff Landes
- Updated New York Retail Worker Safety Act Takes Effect Soon
- Video: Independent Contractor Rule, EEO-1 Reporting, and New York Labor Law Amendment - Employment Law This Week
- Colorado’s Historic AI Law Survives Without Delay (So Far)
- Disparate Impact Liability Under Fire